These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2248074

  • 1. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
    Bizière K, Berger M.
    Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
    [Abstract] [Full Text] [Related]

  • 2. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M, Moll E.
    Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
    [Abstract] [Full Text] [Related]

  • 3. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W.
    Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y, Guelfi JD.
    Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
    [Abstract] [Full Text] [Related]

  • 5. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP, Tsoi WF.
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R, Márquez CA, Traballi CA, Portes N.
    Acta Psychiatr Scand Suppl; 1990 Feb; 360():54-6. PubMed ID: 2123367
    [Abstract] [Full Text] [Related]

  • 7. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M, Amrein R, Stabl M.
    Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
    Baumhackl U, Bizière K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E, Stabl M.
    Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
    [Abstract] [Full Text] [Related]

  • 9. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M, Nardi AE, Figueira IL, Stabl M.
    Acta Psychiatr Scand Suppl; 1990 Oct; 360():24-8. PubMed ID: 2123366
    [Abstract] [Full Text] [Related]

  • 10. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M, Biziére K, Schmid-Burgk W, Amrein R.
    J Neural Transm Suppl; 1989 Oct; 28():77-89. PubMed ID: 2677244
    [Abstract] [Full Text] [Related]

  • 11. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
    Int Clin Psychopharmacol; 1994 Oct; 9(2):109-13. PubMed ID: 8056992
    [Abstract] [Full Text] [Related]

  • 12. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Acta Psychiatr Scand Suppl; 1990 Oct; 360():46-7. PubMed ID: 2248069
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
    Hebenstreit GF, Loidl M, Baumhackl U, Gallhofer B, Geretsegger C, Radmayr E, Saletu M, Schöny W, Stabl M.
    J Neural Transm Suppl; 1990 Oct; 32():177-84. PubMed ID: 2089087
    [Abstract] [Full Text] [Related]

  • 14. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M, Nardi AE, Mundim FD, Alves AB.
    J Neural Transm Suppl; 1989 Oct; 28():65-75. PubMed ID: 2794994
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M, Guelfi JD.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [Abstract] [Full Text] [Related]

  • 16. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.
    Pancheri P, Delle Chiaie R, Donnini M, Seripa S, Gambino C, Vicario E, Trillo L.
    Clin Neuropharmacol; 1994 Sep; 17 Suppl 1():S58-73. PubMed ID: 7954485
    [Abstract] [Full Text] [Related]

  • 17. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium.
    Beckers G, Vereecken A, de Bleeker E, Jaunes C, Sieben G, Faidherbe J, Wolfrum C, Berger M, Hellstern K, Ward J.
    Acta Psychiatr Scand Suppl; 1990 Sep; 360():52-3. PubMed ID: 2248072
    [Abstract] [Full Text] [Related]

  • 18. Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
    Rimón R, Jääskeläinen J, Kaartinen P, Kalli A, Kilponen E, Koskinen T, Nikkilä H, Pirttiperä V, Seppälä J.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):141-7. PubMed ID: 8468435
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Botte L, Gilles C, Evrard JL, Mesters P, Wolfrum C, Berger M, Hellstern K, Ward J.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():42. PubMed ID: 2248066
    [Abstract] [Full Text] [Related]

  • 20. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():48-9. PubMed ID: 2248070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.